Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Relmada Therapeutics Inc’s stock clocked out at $0.40, down -5.05% from its previous closing price of $0.42. In other words, the price has decreased by -$5.05 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
To gain a deeper understanding of RLMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.45 and its Current Ratio is at 4.45. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on December 05, 2024, Downgraded its rating to Neutral and sets its target price to $1 from $23 previously.
On September 17, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $3.50 to $13.
Goldman Downgraded its Neutral to Sell on June 05, 2024, whereas the target price for the stock was revised from $3 to $2.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 11 ’24 when TRAVERSA SERGIO bought 51,407 shares for $2.99 per share. The transaction valued at 153,707 led to the insider holds 384,024 shares of the business.
TRAVERSA SERGIO bought 55,579 shares of RLMD for $150,619 on Sep 09 ’24. The Chief Executive Officer now owns 299,603 shares after completing the transaction at $2.71 per share. On Sep 10 ’24, another insider, TRAVERSA SERGIO, who serves as the Chief Executive Officer of the company, bought 33,014 shares for $2.75 each. As a result, the insider paid 90,788 and bolstered with 332,617 shares of the company.
Stock Price History:
Over the past 52 weeks, RLMD has reached a high of $4.47, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 21.58%, while the 200-Day Moving Average is calculated to be -75.85%.
Shares Statistics:
A total of 30.17M shares are outstanding, with a floating share count of 27.81M. Insiders hold about 16.22% of the company’s shares, while institutions hold 31.34% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.95 and -$0.95 for the fiscal current year, implying an average EPS of -$0.95. EPS for the following year is -$0.8, with 1.0 analysts recommending between -$0.8 and -$0.8.
